Skip to content

Author

Seunghyun Ahn

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Aurone Derivatives as Inhibitors of ERK Phosphorylation in HCC827 Non-Small Cell Lung Cancer Cells.

This study identifies d4 as a promising lead compound that targets ERK-mediated signaling in HCC827 NSCLC cells and highlights the therapeutic potential of the (Z)-2-benzylidenebenzofuran-3(2H)-one structure in inhibiting hyperactivated MAPK signaling.

Junekyu Han, Seunghyun Ahn, Euitaek Jung et al. · 0 citations
Sep 2026

6-(2-Hydroxybenzoyl)pyrazolo[1,5-a]pyrimidine-3‑carbonitriles as novel reactive oxygen species-generating anticancer agents inducing ER stress and DNA damage in EGFR-mutant non-small cell lung cancer.

Findings establish HBP-10 as a highly promising anticancer hit compound for the development of next-generation therapeutic agents, targeting ROS-mediated cellular stress in EGFR-mutant NSCLC.

Jiseong Baek, Seunghyun Ahn, Heewon Kang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.